Trial intelligence / Profile preview

Phase III randomized open-label trial of RPR109881 versus capecitabine in previously treated metastatic breast cancer

2004-000618-38Phase 3Completed

Sponsor

Sanofi

Start

Sep 2005

Modality

Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Irreversible Covalent Inhibitors → Covalent Small Molecules → Small Molecules, DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules

Countries

1